Investing.com – Arrowhead Pharma’s fourth-quarter report fell short of analyst expectations. The report was released on Monday and the company reported lower-than-expected revenue.
Earnings per share were -$0.80, while revenue was $31.57 million. Investing.com market polls indicated that earnings per share are expected to be -$0.42 and the company’s earnings will be $44.86 million. Well and in terms of last quarter
For the year, shares of Arrowhead Pharma fell 57%, underperforming the Nasdaq, which is down 29.37% for the year.
Arrowhead Pharma shares continue sector profits Health care other this month
On January 1, Lilly, Eli & Co. reported third quarter earnings per share of $1.98 on revenue of $6.94 billion, compared with expectations for earnings per share of $1.91 on revenue of $6.91 billion.
Pfizer Inc. earnings beat analyst expectations on Q1, through the third quarter, with quarterly earnings per share of $1.78 and revenue of $22.6 billion. Investing.com analysts expect earnings of $1.44 on revenue of $21.33 billion.
